Relating to access to certain investigational drugs, biological products, and devices used in clinical trials by patients with severe chronic diseases.
Relating to access to certain investigational drugs, biological products, and devices used in clinical trials by patients with severe chronic diseases.
Relating to disclosure of certain complaint and investigation information by the Texas State Board of Pharmacy to the United States Food and Drug Administration.